Skip to Content

AllerNaze Approval History

  • FDA approved: Yes (First approved January 7th, 2009)
  • Brand name: AllerNaze
  • Generic name: triamcinolone acetonide
  • Dosage form: Nasal Spray
  • Previous name: AllerNase
  • Company: Collegium Pharmaceutical, Inc.
  • Treatment for: Allergic Rhinitis

AllerNaze, formerly Tri-Nasal (triamcinolone acetonide, USP) is a reformulated aqueous intranasal steroid nasal spray indicated for the once daily treatment of nasal symptoms associated with both seasonal and perennial allergic rhinitis in adults and children twelve years of age and older.

Development History and FDA Approval Process for AllerNaze

Jan  8, 2009Approval Collegium Pharmaceutical Announces FDA Approval of AllerNaze, a Nasal Inhaled Steroid for the Treatment of Allergic Rhinitis
Apr  8, 2008Collegium Pharmaceutical Announces FDA Filing for AllerNase, a Nasal Inhaled Steroid for the Treatment of Allergic Rhinitis

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.